Literature DB >> 9567450

Cytokeratin intermediate filaments in oral and odontogenic epithelia.

B K Berkovitz1, A W Barrett.   

Abstract

With the development of monoclonal antibodies, the intermediate filaments of the cytoskeleton have attracted a great deal of interest in the last twenty years. Because they are highly antigenic, they could be easily identified using immunohistochemical methods and their specificity for one type of cell offered possibilities in the field of diagnostic pathology. The intermediate filaments most specific for epithelial cells are the cytokeratins (CK). After CK were classified, and certain "rules" regarding CK defined, research proceeded a pace to investigate epithelia in a vast array of anatomical and pathological situations. However, much of the immunohistochemical data that was generated during the 1980's was difficult to digest and some difficult to interpret. Reasons for this include identification of CK by molecular weight rather than CK number, or confusion as to which CK were being labelled by a particular antibody clone known to detect more than one CK. The aim of this article is therefore to present a digest of current knowledge of the CK present within the epithelium of the oral cavity (including the odontogenic epithelium) and its glandular component, and to highlight the significance of the CK phenotype in our understanding of pathological change.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9567450

Source DB:  PubMed          Journal:  Bull Group Int Rech Sci Stomatol Odontol        ISSN: 0250-4693


  2 in total

1.  Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma.

Authors:  Rebeca Souza Azevedo; Oslei Paes de Almeida; Luiz Paulo Kowalski; Fábio Ramôa Pires
Journal:  Head Neck Pathol       Date:  2008-08-08

2.  The expression of cytokeratin in keratocystic odontogenic tumor, orthokeratinized odontogenic cyst, dentigerous cyst, radicular cyst and dermoid cyst.

Authors:  Kaname Tsuji; Masahiro Wato; Teruyoshi Hayashi; Norihiro Yasuda; Takumi Matsushita; Tomohiko Ito; Shoko Gamoh; Hiroaki Yoshida; Akio Tanaka; Shosuke Morita
Journal:  Med Mol Morphol       Date:  2013-10-02       Impact factor: 2.309

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.